Pfizer’s Talzenna/Xtandi Combo Hits On OS Endpoint In Prostate Cancer

 
• By Jessica Merrill
  
Pfizer announced positive overall survival data in metastatic prostate cancer • Source: Shutterstock

More from Anticancer

More from Therapy Areas